COMMUNITY HEALTH SYSTEMS INC (CYH) Stock Fundamental Analysis
USA - NYSE:CYH - US2036681086 - Common Stock
3.12 USD
+0.11 (+3.65%)
3.13 USD
+0.01 (+0.32%)
Overall CYH gets a fundamental rating of 3 out of 10. We evaluated CYH against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CYH while its profitability can be described as average. CYH is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CYH has reported negative net income.
CYH had a positive operating cash flow in the past year.
In multiple years CYH reported negative net income over the last 5 years.
CYH had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of -1.41%, CYH perfoms like the industry average, outperforming 42.57% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.13%, CYH is doing good in the industry, outperforming 63.37% of the companies in the same industry.
CYH had an Average Return On Invested Capital over the past 3 years of 5.27%. This is below the industry average of 9.19%.
The last Return On Invested Capital (6.13%) for CYH is above the 3 year average (5.27%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.41% | ||
| ROE | N/A | ||
| ROIC | 6.13% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
1.3 Margins
The Operating Margin of CYH (6.96%) is better than 68.32% of its industry peers.
CYH's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 84.71%, CYH belongs to the top of the industry, outperforming 97.03% of the companies in the same industry.
In the last couple of years the Gross Margin of CYH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.96% | ||
| PM (TTM) | N/A | ||
| GM | 84.71% |
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CYH is creating some value.
CYH has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CYH has been increased compared to 5 years ago.
CYH has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.89, we must say that CYH is in the distress zone and has some risk of bankruptcy.
CYH has a Altman-Z score of 0.89. This is in the lower half of the industry: CYH underperforms 74.26% of its industry peers.
CYH has a debt to FCF ratio of 79.88. This is a negative value and a sign of low solvency as CYH would need 79.88 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 79.88, CYH is doing worse than 62.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 79.88 | ||
| Altman-Z | 0.89 |
ROIC/WACC1.12
WACC5.49%
2.3 Liquidity
A Current Ratio of 1.59 indicates that CYH should not have too much problems paying its short term obligations.
CYH has a Current ratio of 1.59. This is comparable to the rest of the industry: CYH outperforms 53.47% of its industry peers.
A Quick Ratio of 1.45 indicates that CYH should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.45, CYH is in line with its industry, outperforming 53.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
CYH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.81%, which is quite impressive.
Looking at the last year, CYH shows a small growth in Revenue. The Revenue has grown by 0.79% in the last year.
CYH shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.89% yearly.
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.59%
Revenue 1Y (TTM)0.79%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%-0.22%
3.2 Future
The Earnings Per Share is expected to grow by 26.88% on average over the next years. This is a very strong growth
Based on estimates for the next years, CYH will show a small growth in Revenue. The Revenue will grow by 2.02% on average per year.
EPS Next Y71.07%
EPS Next 2Y37.43%
EPS Next 3Y26.88%
EPS Next 5YN/A
Revenue Next Year-0.56%
Revenue Next 2Y0.94%
Revenue Next 3Y2.02%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CYH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CYH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CYH is valued cheaply inside the industry as 80.20% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CYH indicates a rather cheap valuation: CYH is cheaper than 98.02% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.21 | ||
| EV/EBITDA | 8.12 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CYH's earnings are expected to grow with 26.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.43%
EPS Next 3Y26.88%
5. Dividend
5.1 Amount
No dividends for CYH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.12
+0.11 (+3.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners82.98%
Inst Owner Change2.6%
Ins Owners7.63%
Ins Owner Change0.04%
Market Cap437.17M
Analysts54.12
Price Target3.5 (12.18%)
Short Float %10.54%
Short Ratio5.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.59%
Min EPS beat(2)52.57%
Max EPS beat(2)62.61%
EPS beat(4)2
Avg EPS beat(4)-138.61%
Min EPS beat(4)-607.99%
Max EPS beat(4)62.61%
EPS beat(8)3
Avg EPS beat(8)-184.07%
EPS beat(12)5
Avg EPS beat(12)-182.87%
EPS beat(16)8
Avg EPS beat(16)-462.39%
Revenue beat(2)2
Avg Revenue beat(2)1.86%
Min Revenue beat(2)0.99%
Max Revenue beat(2)2.72%
Revenue beat(4)3
Avg Revenue beat(4)1.4%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)2.72%
Revenue beat(8)5
Avg Revenue beat(8)0.82%
Revenue beat(12)6
Avg Revenue beat(12)0.4%
Revenue beat(16)8
Avg Revenue beat(16)-0.08%
PT rev (1m)0%
PT rev (3m)-18.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.75%
EPS NY rev (1m)23.18%
EPS NY rev (3m)-19.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | 3.21 | ||
| P/OCF | 0.89 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.12 |
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)0.97
FCFY31.11%
OCF(TTM)3.5
OCFY112.31%
SpS90.26
BVpS-11.64
TBVpS-37.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.41% | ||
| ROE | N/A | ||
| ROCE | 7.76% | ||
| ROIC | 6.13% | ||
| ROICexc | 6.38% | ||
| ROICexgc | 9.54% | ||
| OM | 6.96% | ||
| PM (TTM) | N/A | ||
| GM | 84.71% | ||
| FCFM | 1.08% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
ROICexc(3y)5.3%
ROICexc(5y)5.61%
ROICexgc(3y)7.93%
ROICexgc(5y)8.5%
ROCE(3y)6.68%
ROCE(5y)6.87%
ROICexcg growth 3Y-11.89%
ROICexcg growth 5Y0.9%
ROICexc growth 3Y-11.33%
ROICexc growth 5Y0.93%
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
F-Score7
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 79.88 | ||
| Debt/EBITDA | 8.11 | ||
| Cap/Depr | 77.85% | ||
| Cap/Sales | 2.81% | ||
| Interest Coverage | 1.12 | ||
| Cash Conversion | 36.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 0.89 |
F-Score7
WACC5.49%
ROIC/WACC1.12
Cap/Depr(3y)81.42%
Cap/Depr(5y)81.99%
Cap/Sales(3y)3.33%
Cap/Sales(5y)3.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.59%
EPS Next Y71.07%
EPS Next 2Y37.43%
EPS Next 3Y26.88%
EPS Next 5YN/A
Revenue 1Y (TTM)0.79%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%-0.22%
Revenue Next Year-0.56%
Revenue Next 2Y0.94%
Revenue Next 3Y2.02%
Revenue Next 5YN/A
EBIT growth 1Y-6.78%
EBIT growth 3Y-12.97%
EBIT growth 5Y-1.39%
EBIT Next Year51.83%
EBIT Next 3Y17.2%
EBIT Next 5YN/A
FCF growth 1Y163.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.17%
OCF growth 3YN/A
OCF growth 5Y4.51%